Details for New Drug Application (NDA): 203576
✉ Email this page to a colleague
The generic ingredient in LEVOLEUCOVORIN CALCIUM is levoleucovorin calcium. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the levoleucovorin calcium profile page.
Summary for 203576
Tradename: | LEVOLEUCOVORIN CALCIUM |
Applicant: | Mylan Teoranta |
Ingredient: | levoleucovorin calcium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203576
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | ||||
Approval Date: | Oct 20, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | ||||
Approval Date: | Oct 20, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription